Evidence map›Paper›PMID 29651838›Full record

ArticleChemical research in toxicology2018

Analysis and Identification of 2'-Deoxyadenosine-Derived Adducts in Lung and Liver DNA of F-344 Rats Treated with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Erik S Carlson, Pramod Upadhyaya, Peter W Villalta, Bin Ma, Stephen S Hecht

Open access · greenAbstract read
In one paragraph

Article in Chemical research in toxicology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. 5-(Pyridin-3-yl)-3,4-dihydro-2Royal Society open science · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. DNA Alkylation Damage by Nitrosamines and Relevant DNA Repair Pathways.International journal of molecular sciences · 2023
    Review
  6. Metabolism and DNA Adduct Formation of Tobacco-SpecificInternational journal of molecular sciences · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Identification of anChemical research in toxicology · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. DNA replication studies ofThe Journal of biological chemistry · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Erik S CarlsonMasonic Cancer Center , University of Minnesota , 2231 Sixth Street SE , 2-210 CCRB, Minneapolis , Minnesota 55455 , United States.
Pramod UpadhyayaMasonic Cancer Center , University of Minnesota , 2231 Sixth Street SE , 2-210 CCRB, Minneapolis , Minnesota 55455 , United States.
Peter W VillaltaMasonic Cancer Center , University of Minnesota , 2231 Sixth Street SE , 2-210 CCRB, Minneapolis , Minnesota 55455 , United States.ORCID 0000-0002-0067-3083
Bin MaMasonic Cancer Center , University of Minnesota , 2231 Sixth Street SE , 2-210 CCRB, Minneapolis , Minnesota 55455 , United States.ORCID 0000-0002-7549-2658
Stephen S HechtMasonic Cancer Center , University of Minnesota , 2231 Sixth Street SE , 2-210 CCRB, Minneapolis , Minnesota 55455 , United States.ORCID 0000-0001-7228-1356
University of Minnesota · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
METABOLISM OF CARCINOGENIC TOBACCO SPECIFIC NITROSAMINESR01CA081301 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI STEPHEN S HECHT · 1999 to 2026
$7.1M
Metabolism of Carcinogenic Tobacco-Specific NitrosaminesR37CA081301 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HECHT, STEPHEN S · 2004 to 2013
$5.5M
Mass Spectrometric Analytical Collaborations with Members of the Masonic Cancer Center of the University of MinnesotaR50CA211256 · NCI · UNIVERSITY OF MINNESOTA · PI Peter William Villalta · 2016 to 2026
$2.1M
NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA081301NCI NIH HHS R37 CA081301NCI NIH HHS R50 CA211256
6 · The paper itself

Abstract

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) are carcinogenic in animal models and are believed to play an important role in human lung carcinogenesis for cigarette smokers. Cytochrome P450-mediated metabolism of these tobacco-specific nitrosamines produces reactive species that alkylate DNA in the form of pyridyloxobutyl (POB)- or pyridylhydroxybutyl (PHB)-DNA adducts. Understanding the formation mechanism and overall levels of these adducts can potentially enhance cancer prevention methods through the identification of particularly susceptible smokers. Previous studies have identified and measured a panel of POB- and PHB-DNA base adducts of dGuo, dCyd, and Thd; however, dAdo adducts have yet to be determined. In this study, we complete this DNA adduct panel by identifying and quantifying levels of NNK- and NNAL-derived dAdo adducts in vitro and in vivo. To accomplish this, we synthesized standards for expected dAdo-derived DNA adducts and used isotope-dilution LC-ESI

Indexed as

LiverLungAnimalsDeoxyadenosinesDNA AdductsMaleMolecular StructureNitrosaminesProhibitinsRatsRats, Inbred F3442'-deoxyadenosine4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneDeoxyadenosinesDNA AdductsNitrosaminesPHB protein, humanPhb protein, ratProhibitins

Identifiers

PMID29651838
PMCPMC5995121
OpenAlexW2796767624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.